Associate Professor, Medicine, UCSF School of Medicine
Gastroenterology
Dr. Uma Mahadevan, MD
|
|
Give Review
Mahadevan is an expert in the field of Gastroenterology. He studied medicine at Mount Sinai School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Doctor Uma Mahadevan, MD is also published. He has 67 publications published. The lastest publication: "Cloning and expression of an acyl-CoA dehydrogenase from Mycobacterium tuberculosis.' Mahadevan is registered with Medicare and accepts Medicare payments.
Publications
- Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol.
- Care of the Pregnant Patient With Inflammatory Bowel Disease.
- Proceedings from the ACR Reproductive Health Summit: The management of fertility, pregnancy and lactation in women with autoimmune and Systemic inflammatory diseases.
- Editorial: the management of IBD during pregnancy and lactation.
- Pharmacokinetics of biologics and the role of therapeutic monitoring.
- A Measured Approach to Crohn's Therapy: Check Levels and Save.
- Insights Into the Molecular Pathophysiology of Inflammatory Bowel Disease: ATG16L1 Suppresses Nod-Driven Inflammation.
- The use of biologic therapy in pregnancy: a gastroenterologist's perspective.
- My treatment approach to management of the pregnant patient with inflammatory bowel Disease.
- Immunoglobulin therapy for refractory Crohn's Disease.
- Popular Exclusionary Diets for Inflammatory Bowel Disease: The Search for a Dietary Culprit.
- Etrolizumab: Anti-β7-A Novel Therapy for Ulcerative Colitis.
- Serologic Markers Associated with Development of Crohn's Disease After Ileal Pouch Anal Anastomosis for Ulcerative Colitis.
- Management of inflammatory bowel Disease in pregnancy.
- Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease.
- Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease.
- Micronutrient deficiencies in inflammatory bowel Disease: From A to zinc.
- Editorial: Are Thiopurines and Anti-TNF? Agents Safe to Use in Pregnant Patients With Inflammatory Bowel Disease?
- Evolving medical therapies for Crohn's Disease.
- Infliximab for the treatment of orofacial Crohn's Disease.
- Intravenous azathioprine in severe Ulcerative colitis: a pilot study.
- Cloning and expression of an acyl-CoA dehydrogenase from Mycobacterium tuberculosis.
- Fistula response to methotrexate in Crohn''s Disease: a case series.
- Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn''s Disease.
- Fertility and pregnancy in the patient with inflammatory bowel Disease.
- Adalimumab use in pregnancy.
- Infliximab and semen quality in men with inflammatory bowel Disease.
- American gastroenterological association institute technical review on the use of gastroIntestinal medications in pregnancy.
- American gastroenterological association institute medical position statement on the use of gastroIntestinal medications in pregnancy.
- Mucosal healing in Crohn's Disease: what you see is what you get?
- Infliximab for the treatment of metastatic hepatic and pulmonary Crohn''s Disease.
- 6TG: when less is more than you bargained for.
- Gross versus microscopic pancolitis and the occurrence of neoplasia in Ulcerative colitis.
- Diagnosis and management of pouchitis.
- Azathioprine or 6-mercaptopurine before colectomy for Ulcerative colitis is not associated with increased postoperative complications.
- Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel Disease.
- Efficacy of anti-TNF therapies in refractory severe microscopic colitis.
- Transitioning the adolescent inflammatory bowel Disease patient: guidelines for the adult and pediatric gastroenterologist.
- The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and...
- IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an Ulcerative colitis patient.
- European evidenced-based consensus on reproduction in inflammatory bowel Disease.
- Inflammatory bowel Disease and pregnancy: an update.
- A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn''s Disease.
- Viral hepatitis and inflammatory bowel Disease.
- Anti-tumor necrosis factor therapy for inflammatory bowel Disease in the setting of immunosuppression for solid organ transplantation.
- Do side-by-side anastomoses decrease the risk of recurrence in Crohn's Disease?
- Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of Ulcerative colitis.
- Use of infliximab in pregnancy.
- Pregnancy and inflammatory bowel Disease.
- Of blemishes and bowels: isotretinoin and inflammatory bowel Disease.
- Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory Ulcerative colitis.
- General health maintenance in IBD.
- An obscure harbinger. Difficult diagnosis of Crohn's Disease.
- A new answer to an old question: azathioprine withdrawal in quiescent Crohn's Disease.
- A 24-year-old pregnant woman with inflammatory bowel Disease.
- Cervical neoplasia risk in IBD: truth or hysteria?
- Angiographic embolization for control of life-threatening hemorrhage from Benign rectal ulcers.
- Infliximab and surgical complications: truth or perception?
- Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's Disease: a randomized, double-blind, placebo-controlled pilot study.
- Management of the pregnant IBD patient.
- A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory Ulcerative colitis.
- GastroIntestinal medications in pregnancy.
- Pregnancy outcomes in women with inflammatory bowel Disease: a large community-based study from Northern California.
- Continuing immunomodulators and biologic medications in pregnant IBD patients - pro.
- Management of steroid-dependent Ulcerative colitis: immunomodulatory agents, biologics, or surgery?
- TNF-alpha antagonists: benefits beyond remission.
Schools
SUNY Downstate Medical Center College Of Medicine
Mt Sinai School Of Med
University Ca Sf School Of Med
Mayo Clinic Rochester
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
- Basic HMO
- Vitalidad Plus California Con Aetna
- Blue Card PPO
- CaliforniaCare HMO
- Blue Cross Blue Shield of California PPO
- Select Plus HMO
- Access Plus Savenet
- Enhanced Exclusive for Small Business HMO
- Local Access Plus HMO
- Brown & Toland Physicians
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Blue & Gold HMO
- Covered California - Bronze PPO
- Employer Group HMO
- Health Net PPO
- Individual and Family PPO
- Medicare Advantage PFFS
- WholeCare Network HMO
- Humana
- Medicare MCR
- Kaiser PHCS Network PPO
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- PacifiCare HMO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
Mount Sinai School of Medicine -
State University of New York Downstate Medical Center College of Medicine
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Drug Facts
| NPI NUMBER | 1851355283 | |
| NPPES Provider LastName | MAHADEVAN | |
| NPPES Provider FirstName | UMA | |
| NPPES Provider ZIPCode | 941153465 | |
| NPPES Provider State | CA | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 671.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851355283 |
| Last Name Of The Provider | MAHADEVAN |
| First Name Of The Provider | UMA |
| View All |
Similar Doctors
|
|
Dr. Lukejohn W. Day, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kenneth F. Binmoeller, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jane S. Melnick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley B. Goldberg, MD |
|
|
Dr. Hayden L. Klaeveman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jacquelyn J. Maher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kidist K. Yimam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amandeep K. Shergill, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chanda K. Ho, MD
This Doctor is OpenDoctor Recommended.
|